ALLMED MEDICAL CARE HOLDINGS LIMITED
Get an alert when ALLMED MEDICAL CARE HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-12 (in 9mo)
Last made up 2026-01-29
Watchouts
Cash
£2M
EUR 2,719,000
-59.4% vs 2023
Net assets
£5M
EUR 5,998,000
-32.9% vs 2023
Employees
1,425
+12.1% vs 2023
Profit before tax
£171K
EUR 197,000
+119.3% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 PSCs ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £50,109,575 | £49,798,243 | |
| Operating profit | £1,094,878 | £2,461,084 | |
| Profit before tax | -£889,643 | £171,319 | |
| Net profit | -£1,110,531 | £1,321,854 | |
| Cash | £5,828,333 | £2,364,553 | |
| Total assets less current liabilities | £9,557,353 | £6,544,047 | |
| Net assets | £7,777,198 | £5,216,106 | |
| Equity | £7,777,198 | £5,216,106 | |
| Average employees | 1,271 | 1,425 | |
| Wages | £4,967,388 | £4,917,819 | |
| Directors' remuneration | £175,667 | £252,196 |
Figures converted to GBP from EUR at 0.870 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-0.6%
£50,109,575 £49,798,243
-
Cash
-59.4%
£5,828,333 £2,364,553
-
Net assets
-32.9%
£7,777,198 £5,216,106
-
Employees
+12.1%
1,271 1,425
-
Operating profit
+124.8%
£1,094,878 £2,461,084
-
Profit before tax
+119.3%
-£889,643 £171,319
-
Wages
-1%
£4,967,388 £4,917,819
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 2.2% | 4.9% | |
| Net margin | -2.2% | 2.7% | |
| Return on capital employed | 11.5% | 37.6% | |
| Gearing (liabilities / total assets) | 82.1% | 84.8% | |
| Current ratio | 1.14x | 1.07x | |
| Interest cover | 0.64x | 1.16x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ALLMED MEDICAL CARE HOLDINGS LIMITED 2012-03-14 → present
- ALLMED MEDICAL CARE HOLDING LIMITED 2012-02-27 → 2012-03-14
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On the basis of their assessment set out above, the Directors believe it is appropriate to prepare the financial statements on a going concern basis.”
Group structure
- ALLMED MEDICAL CARE HOLDINGS LIMITED · parent
- Allmed Medical GmbH ("AMG") 100%
- Allmed India Pvt Ltd(" AIN") 95%
- Allmed Polska Sp. Z o.o. ("APL") 100%
- Allmed Medical Nominee No. 1 Limited ("AMN1"") 100%
- Allmed Medical Logistics Limited 100%
- Allmed Middle East S.A.E. ("AME") 99%
- Allmed Medical Industries GmbH ("AMI") 93%
- NephroCan GmbH & Co. KG 49%
- Allmed Dialysis Technologies GmbH ("ADT") 100%
- Allmed Turkey Medikal Ticaret Limited Sirketi ("ATM") 90%
- Allmed Pronefro Brasil Ltda* ("ABR") 94%
Significant events
- “On 16 April 2025 the Group restructured its senior finance facility and Rand Merchant Bank Limited ("RMB") as part of its overall strategic growth plan.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CONNELL, Rupert Mark Angus | Secretary | 2014-12-18 | — | — |
| BRENNAN, Thomas Christopher | Director | 2024-02-01 | Jan 1966 | Irish |
| EMARA, Omar Esameldin Abdelrahman Abdelmagid | Director | 2024-09-27 | Jun 1995 | Egyptian |
| FOND, Zachary Daniel | Director | 2024-09-27 | Aug 1983 | British |
| JETHA, Afsane | Director | 2024-09-27 | Jul 1979 | British |
| SOROUR, Ahmed Hany Mamdouh Mohamed | Director | 2012-02-27 | Jan 1988 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SPEECHLY BIRCHAM LLP | Corporate Secretary | 2012-02-27 | 2013-03-07 |
| BRENNAN, Thomas Christopher, Mr. | Director | 2019-11-05 | 2021-07-09 |
| HADHOUD, Mousheer Mohamed Abdelfattah Ghareeb | Director | 2020-12-17 | 2023-07-20 |
| SOROUR, Hany Mamdouh Mohamed, Dr | Director | 2020-12-17 | 2024-06-26 |
| SOROUR, Lena Hany Mamdouh Mohamed | Director | 2021-07-09 | 2024-02-01 |
| GRANDVIEW INVESTEMENT HOLDINGS CORP | Corporate Director | 2014-07-03 | 2023-07-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ms Afsane Jetha | Individual | Significant influence | 2024-06-26 | Active |
| Mr Shoaib Abedi | Individual | Shares 25–50%, Voting 25–50% | 2023-07-20 | Ceased 2024-06-26 |
| Mr Ahmed Hany Mamdouh Sorour | Individual | Shares 25–50% | 2016-04-06 | Ceased 2024-07-22 |
| Mr Hany Mamdouh Mohamed Sorour | Individual | Shares 25–50% | 2016-04-06 | Ceased 2024-06-26 |
Filing timeline
Last 20 of 91 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-12-30 RESOLUTIONS Resolution
- 2025-05-02 MA Memorandum articles
- 2025-05-02 RESOLUTIONS Resolution
- 2025-04-09 MA Memorandum articles
- 2025-04-09 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-04 | AA | accounts | Accounts with accounts type group | |
| 2026-02-02 | SH08 | capital | Capital name of class of shares | |
| 2026-01-31 | SH10 | capital | Capital variation of rights attached to shares | |
| 2026-01-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-30 | SH20 | capital | Legacy | |
| 2025-12-30 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-12-30 | CAP-SS | insolvency | Legacy | |
| 2025-12-30 | RESOLUTIONS | resolution | Resolution | |
| 2025-12-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-24 | CH01 | officers | Change person director company with change date | |
| 2025-12-24 | CH01 | officers | Change person director company with change date | |
| 2025-05-02 | MA | incorporation | Memorandum articles | |
| 2025-05-02 | RESOLUTIONS | resolution | Resolution | |
| 2025-04-28 | CH01 | officers | Change person director company with change date | |
| 2025-04-22 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-04-22 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-04-09 | MA | incorporation | Memorandum articles | |
| 2025-04-09 | RESOLUTIONS | resolution | Resolution | |
| 2025-01-07 | AA | accounts | Accounts with accounts type group | |
| 2024-12-21 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 13
- Capital events
- 4
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.